Literature DB >> 17435082

PDUFA reauthorization--drug safety's golden moment of opportunity?

Sean Hennessy1, Brian L Strom.   

Abstract

Mesh：

Year:  2007        PMID： 17435082     DOI： 10.1056/NEJMp078048

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  A pharmacoepidemiological network model for drug safety surveillance: statins and rhabdomyolysis.

Authors:  Ben Y Reis; Karen L Olson; Lu Tian; Rhonda L Bohn; John S Brownstein; Peter J Park; Mark J Cziraky; Marcus D Wilson; Kenneth D Mandl
Journal:  Drug Saf       Date:  2012-05-01       Impact factor: 5.606

Review 2.  Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.

Authors:  Russell A Wilke; Debbie W Lin; Dan M Roden; Paul B Watkins; David Flockhart; Issam Zineh; Kathleen M Giacomini; Ronald M Krauss
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

Review 3.  Active pharmacovigilance in China: recent development and future perspectives.

Authors:  Xinling Li; Haona Li; Jianxiong Deng; Feng Zhu; Ying Liu; Wenge Chen; Zhihua Yue; Xuequn Ren; Jielai Xia
Journal:  Eur J Clin Pharmacol       Date:  2018-04-10       Impact factor: 2.953

Review 4.  Pharmacovigilance: methods, recent developments and future perspectives.

Authors:  L Härmark; A C van Grootheest
Journal:  Eur J Clin Pharmacol       Date:  2008-06-04       Impact factor: 2.953

Review 5.  Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association?

Authors:  Helen V Danesh-Meyer; Leonard A Levin
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

6.  Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases.

Authors:  Jeremy A Rassen; Jerry Avorn; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-08       Impact factor: 2.890

Review 7.  Use of Biomedical Ontologies for Integration of Biological Knowledge for Learning and Prediction of Adverse Drug Reactions.

Authors:  Shadia Zaman; Sirarat Sarntivijai; Darrell R Abernethy
Journal:  Gene Regul Syst Bio       Date:  2017-03-15

8.  Adverse drug reactions in hospitalized Colombian children.

Authors:  Roxana de Las Salas; Daniela Díaz-Agudelo; Francisco Javier Burgos-Flórez; Claudia Vaca; Dolores Vanessa Serrano-Meriño
Journal:  Colomb Med (Cali)       Date:  2016-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.